Can You Overdose on Mounjaro, and What Happens If You Take Too Much?

There is no published lethal dose threshold for tirzepatide in humans, but overdose can cause severe nausea, vomiting, low blood sugar and dehydration serious enough to need hospital treatment.
The most common route to accidental overdose is injecting a second dose too soon, for example, forgetting a weekly injection has already been given.
If you suspect an overdose, call NHS 111 immediately or go to A&E; do not wait for symptoms to develop.
The Mounjaro KwikPen is designed to deliver one fixed dose per injection, it cannot be "dialled up", but using two pens close together carries real risk.

Taking more tirzepatide than prescribed is a genuine clinical concern. An overdose of Mounjaro — whether from injecting twice in error or from a dose taken too soon — does not cause the same kind of acute emergency as an insulin overdose, but it can trigger serious gastrointestinal harm and requires prompt medical attention. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses your full health picture before any pen is dispensed, precisely because dose and timing matter.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the clinical evidence and MHRA guidance tell us about Mounjaro overdose

What official guidance says about taking too much tirzepatide

The Mounjaro Summary of Product Characteristics, held on the electronic Medicines Compendium, describes overdose management straightforwardly: start supportive treatment matched to the symptoms. There is no specific antidote. That framing matters. It tells us that an overdose of Mounjaro is not treated like a paracetamol overdose, where a timed intervention can reverse damage, instead, clinicians manage whatever the body is doing in response to excess tirzepatide, which is mostly severe gastrointestinal distress and, in people with diabetes or borderline glucose levels, hypoglycaemia.

Clinical trial data from the SURMOUNT programme, which followed thousands of adults over 72 weeks, showed that the most commonly reported dose-related harms were gastrointestinal. At higher therapeutic doses nausea, vomiting and diarrhoea became more frequent. Pushing beyond a therapeutic dose amplifies those effects, adds the risk of significant dehydration, and (if kidneys are already under strain) can accelerate kidney stress through fluid loss alone.

The MHRA's published guidance on GLP-1 medicines reinforces this picture. The regulator tracks spontaneous reports of adverse events, and serious complications from tirzepatide are, to date, predominantly gastrointestinal rather than cardiac or neurological. That is not a reason for complacency; dehydration that goes untreated can cascade quickly, particularly in older adults. Anyone over 75 taking Mounjaro should be especially alert to this, and there are specific considerations for that age group worth reading before starting.

How accidental overdose actually happens, and how to avoid it

The Mounjaro KwikPen delivers one fixed subcutaneous dose. You cannot accidentally inject more than that single dose from one pen, the mechanism prevents it. The realistic overdose scenario is a second pen used too soon: an injection given on Monday, then another given on Tuesday because the person forgot the first, or stored an extra pen and confused the dates.

A practical habit that works for many people is keeping a small calendar note near wherever the pen is stored. Most pens are refrigerated, and a sticker on the fridge door with the injection day marked is low-tech but effective. If you keep your pen in a secondary location at home or travel with treatment, a phone reminder set weekly removes most of the ambiguity.

Injecting two therapeutic doses within 24 to 48 hours of each other means the body is processing roughly double the active ingredient it expects over that window. Tirzepatide has a half-life of around five days, so the second dose does not simply cancel out, it stacks on top of a residual level that is already doing its job. The result can be intense nausea, repeated vomiting, and a blood-sugar drop that needs monitoring or treatment.

If there is any doubt about whether a dose was already given, the safest approach is to skip and resume on the normal schedule the following week, then tell the prescriber. This is the guidance published on the NHS tirzepatide medicines page. Do not try to compensate for a missed dose by doubling up.

Symptoms to watch for and when to call for help

Mounjaro overdose symptoms range from the uncomfortable to the serious, and they can develop over several hours rather than immediately. Mild cases may feel like a bad episode of treatment-related nausea, queasy, off food, some loose stools. More significant overdose produces persistent vomiting that prevents keeping fluids down, severe stomach cramping, dizziness on standing, and a rapid heartbeat from dehydration. In people who also take insulin or sulfonylureas, blood sugar can drop to a level that causes confusion, sweating or fainting.

Call NHS 111 straight away if you think you or someone else has taken too much tirzepatide. Go directly to A&E if there is vomiting that will not stop, severe abdominal pain that radiates to the back (which may signal pancreatitis, a known though infrequent risk with GLP-1 medicines flagged in an MHRA Drug Safety Update in January 2026), fainting, confusion, or chest tightness. Do not wait to see if it settles. Take the pen or its packaging with you so the team knows exactly what was administered and when.

For a fuller breakdown of what an overdose presentation can involve, the dedicated page on Mounjaro overdose symptoms covers the clinical picture in more detail. And if you are wondering whether the medication is actually working as expected, questions about weight loss stalling on Mounjaro are common and worth exploring separately.

The role of clinical oversight in preventing overdose

Overdose risk is one of the reasons Mounjaro is a prescription-only medicine, not something available freely. A clinical consultation is not a formality, a real prescriber, not automated software, assesses whether the dose you are on is appropriate, flags interaction risks, and documents your schedule. At nume, that review happens the same day you submit your consultation, and every repeat order is checked by a GPhC-registered Independent Prescriber before anything is dispensed.

That structure matters for safety. If a prescriber knows you are also taking a medicine that affects blood glucose or one that slows gastric motility, they can factor that into your dose plan. Self-sourcing tirzepatide from unverified sellers (sellers who supply without a prescription or any clinical assessment) removes that safeguard entirely. The MHRA has raided illicit manufacturing sites producing counterfeit tirzepatide pens; what is in those pens is unknown, which makes any dosing estimate meaningless and overdose unpredictable. You can check whether any online pharmacy is legitimate on the GPhC pharmacy register.

If cost is part of why someone considers unverified sources, the real picture of Mounjaro pricing in the UK is worth reading first, the gap between legitimate and counterfeit supply is not as wide as it might seem, and the risks are not comparable. When you are ready to speak to a prescriber about starting or continuing treatment safely, start your free consultation with nume here.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions